265 related articles for article (PubMed ID: 27603572)
1. Advances and challenges in hereditary cancer pharmacogenetics.
Cascorbi I; Werk AN
Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):73-82. PubMed ID: 27603572
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
Bosch TM; Meijerman I; Beijnen JH; Schellens JH
Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
[TBL] [Abstract][Full Text] [Related]
3. Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Wellmann R; Borden BA; Danahey K; Nanda R; Polite BN; Stadler WM; Ratain MJ; O'Donnell PH
Cancer; 2018 Jul; 124(14):3052-3065. PubMed ID: 29742281
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of Pharmacogenetics.
Quaranta S; Thomas F
Therapie; 2017 Apr; 72(2):205-215. PubMed ID: 28262261
[TBL] [Abstract][Full Text] [Related]
5. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Deeken JF; Figg WD; Bates SE; Sparreboom A
Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia.
Cavic M; Krivokuca A; Boljevic I; Brotto K; Jovanovic K; Tanic M; Filipovic L; Zec M; Malisic E; Jankovic R; Radulovic S
J BUON; 2016; 21(5):1287-1295. PubMed ID: 27837635
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics in cancer treatment.
Nagasubramanian R; Innocenti F; Ratain MJ
Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
[TBL] [Abstract][Full Text] [Related]
8. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
Cecchin E; De Mattia E; Ecca F; Toffoli G
Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing.
Guchelaar HJ; Gelderblom H; van der Straaten T; Schellens JH; Swen JJ
Clin Pharmacol Ther; 2014 Apr; 95(4):383-5. PubMed ID: 24448475
[TBL] [Abstract][Full Text] [Related]
10. The role of pharmacogenetics in capecitabine efficacy and toxicity.
Lam SW; Guchelaar HJ; Boven E
Cancer Treat Rev; 2016 Nov; 50():9-22. PubMed ID: 27569869
[TBL] [Abstract][Full Text] [Related]
11. Using pharmacogene polymorphism panels to detect germline pharmacodynamic markers in oncology.
Hertz DL; McLeod HL
Clin Cancer Res; 2014 May; 20(10):2530-40. PubMed ID: 24831276
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
13. Germline variants in cancer therapy.
Kaehler M; Cascorbi I
Cancer Drug Resist; 2019; 2(1):18-30. PubMed ID: 35582146
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics and cancer therapy.
Relling MV; Dervieux T
Nat Rev Cancer; 2001 Nov; 1(2):99-108. PubMed ID: 11905809
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
Hasegawa Y
Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
[TBL] [Abstract][Full Text] [Related]
17. [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?].
Lehne G; Bjørheim J; Saeter G
Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1040-4. PubMed ID: 17457389
[TBL] [Abstract][Full Text] [Related]
18. PharmFrag: An Easy and Fast Multiplex Pharmacogenetics Assay to Simultaneously Analyze 9 Genetic Polymorphisms Involved in Response Variability of Anticancer Drugs.
Bouvet R; Verdier MC; El Baroudi Y; Galibert MD; David V; Schutz S; Tron C
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348915
[TBL] [Abstract][Full Text] [Related]
19. Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.
Bertholee D; Maring JG; van Kuilenburg AB
Clin Pharmacokinet; 2017 Apr; 56(4):317-337. PubMed ID: 27641154
[TBL] [Abstract][Full Text] [Related]
20. [SNPs associated with adverse effects].
Isomura M; Miki Y
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1908-13. PubMed ID: 16282725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
